The Veteran's chronic eczematoid dermatitis is being remanded for a VA examination to determine if it is related to his service, including exposure to herbicides.
The deciding factor: There is insufficient competent medical evidence to make a decision regarding the nature and origin of the Veteran’s skin condition.
- Claimed conditions
- chronic eczematoid dermatitis
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 14, 2019
- Citation
- 19146513
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's chronic eczematoid dermatitis is being remanded for further examination and opinion to determine if it is related to his in-service exposure to herbicide agents.
- Remanded (sent back)
The Board has remanded the case due to insufficient evidence regarding whether the veteran's service-connected skin condition contributed to his death. The appellant must provide additional medical opinions and VA will review the claim.
- Remanded (sent back)
The Board remands the claim for a medical opinion addressing whether the Veteran's left eye condition is related to service, as it found that the condition did not preexist service.
- Granted
The Board granted service connection for prostate cancer, related to in-service exposures at Camp Lejeune.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.